Galaxy Medicare IPO
IPO Listing Details
- Listing Date
17 Sep 2025
- Listing Price
₹ 54.00
- Listing Change
0.00%
- Last Traded Price
₹ 20.75
Galaxy Medicare IPO Details
-
Open Date
10 Sep 2025
-
Close Date
12 Sep 2025
-
Listing Date
17 Sep 2025
- IPO Price Range
₹ 51 to ₹54
- IPO Size
₹ 22.31 Cr
- Listing Exchange
NSE SME
Galaxy Medicare IPO Timeline
Galaxy Medicare IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 10-Sep-25 | 1.00 | 0.66 | 0.33 | 0.47 |
| 11-Sep-25 | 1.00 | 1.05 | 0.70 | 0.84 |
| 12-Sep-25 | 1.00 | 1.48 | 2.10 | 1.83 |
Last Updated: 15 September 2025 11:46 AM by 5paisa
Galaxy Medicare Limited, incorporated in 1992 in Bhubaneswar, Odisha, is a healthcare products manufacturer specialising in Plaster of Paris (POP) bandages, medical dressings, and wound-care consumables. Over the last three decades, the company has built a strong presence in both domestic and export markets, catering to hospitals, government institutions, and OEM clients. With certifications such as ISO 13485:2016 and CE, Galaxy Medicare has positioned itself as a reliable supplier with a focus on quality and compliance.
The company operates across branded sales, institutional tenders, and exports, ensuring multiple revenue streams. By leveraging its long-standing expertise, Galaxy Medicare aims to scale operations further through manufacturing expansion and product diversification. Its upcoming IPO is designed to strengthen working capital, upgrade capacity, and capture emerging demand in India’s rapidly expanding healthcare and medical consumables sector.
Established in: 1992
Managing Director: Mr. Dillip Kumar Das
Galaxy Medicare Objectives
Raise funds to expand its existing manufacturing facility in Bhubaneswar by investing in new machinery.
Support working capital needs to meet growing operational demands.
Deploy proceeds for general corporate purposes, including servicing the IPO and related offer expenses.
Galaxy Medicare IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹22.31 Cr |
| Offer For Sale | ₹4.45 Cr |
| Fresh Issue | ₹16.71 Cr |
Galaxy Medicare IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | 2,04,000 |
| Retail (Max) | 2 | 4,000 | 2,04,000 |
| S-HNI (Min) | 3 | 6,000 | 3,24,000 |
| S-HNI (Max) | 7 | 14,000 | 7,56,000 |
| B-HNI (Min) | 8 | 16,000 | 7,64,000 |
Galaxy Medicare IPO Reservation
| Investors Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB (Ex Anchor) | 1.00 | 80,000 | 80,000 | 0.432 |
| NII (HNI) | 1.48 | 15,36,000 | 22,66,000 | 12.236 |
| Individual Investors (IND category bidding for 2 Lots) | 2.10 | 23,08,000 | 48,44,000 | 26.158 |
| Total** | 1.83 | 39,24,000 | 71,90,000 | 38.826 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (in Rs. Crores) | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | 30.73 | 32.02 | 36.93 |
| EBITDA | 0.94 | 3.13 | 5.26 |
| PAT | -0.21 | 1.57 | 3.7 |
| Particulars (in Rs. Crores) | FY22 | FY23 | FY24 |
|---|---|---|---|
| Total Assets | 13.91 | 15.29 | 15.26 |
| Share Capital | 3.04 | 3.04 | 11.86 |
| Total Borrowing | 9.92 | 9.14 | 8.12 |
| Particulars (in Rs. Crores) | FY22 | FY23 | FY24 |
|---|---|---|---|
| Net Cash Generated From / (used in) operating activities | -0.56 | 3.65 | 2.7 |
| Net Cash Generated From / (used in) investing activities | -0.57 | -1.91 | -0.65 |
| Net Cash Generated From / (used in) financing activities | 1.19 | -1.8 | -2.07 |
| Net Increase (Decrease) In Cash And Cash Equivalents | 5.38 | -6.5 | -2.5 |
Strengths
1. Long-standing business with a legacy of more than three decades and strong customer relationships.
2. Strong quality credentials, including ISO 13485:2016 and CE certification.
3. Dual-revenue streams including branded products, institutional sales, exports, and OEM activities
Weaknesses
1. Revenue and profitability depend on a limited number of key customers, increasing concentration risk.
2. Vulnerable to fluctuations in raw material supply and cost inflation.
3. Export operations expose the firm to geopolitical or economic shifts abroad.
Opportunities
1. Growing domestic and global demand for wound-care and medical dressing products.
2. Potential for deeper market penetration via government tenders (e.g., GEM platform) and export markets.
3. Expansion potential through operational scale-up and extended product portfolio.
Threats
1. Intense competition from larger domestic players or imports.
2. Regulatory changes or trade barriers could disrupt export volumes.
3. Execution risks linked to rapid infrastructure expansion or funding deployment.
Galaxy Medicare offers a combination of legacy business strength, diversified revenue streams, strong quality compliance, and targeted use of proceeds to fuel manufacturing expansion. The tender-based institutional and export segments offer added visibility for future order flows. However investors should weigh this against customer concentration risk, supply sensitivities, and execution challenges before subscribing.
The global demand for medical dressing products such as POP bandages and surgical dressings is rising steadily. India’s healthcare infrastructure expansion and increasing public procurement via government schemes further boost demand. The domestic medical supplies market, valued in the thousands of crores, is expected to grow at a healthy CAGR, presenting Galaxy Medicare with potential for scalable growth in both domestic and export markets.
- Companies
- Type
- Opening On
-
Unisem Agritech Ltd
- SME
- 10th Dec
- Pre-Book
-
Shipwaves Online
- SME
- 10th Dec
- Pre-Book
-
Nephrocare Health Services
- Mainboard
- 10th Dec
- Pre-Book
-
ICICI Prudential Asset Management Co
- Mainboard
- 12th Dec
- Pre-Book
-
Park Medi World
- Mainboard
- 10th Dec
- Pre-Book
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Galaxy Medicare IPO opens from September 10, 2025 to September 12, 2025.
The size of Galaxy Medicare IPO is ₹22.31 Cr.
The price band of Galaxy Medicare IPO is fixed at ₹51 to ₹54 per share.
To apply for Galaxy Medicare IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Galaxy Medicare IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Galaxy Medicare IPO is of 2 lots consisting of 4,000 shares and the investment required is ₹2,04,000.
The share allotment date of Galaxy Medicare IPO is September 16, 2025.
The Galaxy Medicare IPO will likely be listed on September 17, 2025.
Affinity Global Capital Market Pvt.Ltd. is the book running lead manager and Cameo Corporate Services Ltd. is the registrar of the issue.
Galaxy Medicare plans to utilise the raised capital from the IPO for:
● Raise funds to expand its existing manufacturing facility in Bhubaneswar by investing in new machinery.
● Support working capital needs to meet growing operational demands.
● Deploy proceeds for general corporate purposes, including servicing the IPO and related offer expenses.
Galaxy Medicare Contact Details
Plot No-2, Zone D,
Phase A, Mancheswar Industrial Estate
Khurda
Bhubaneshwar, Odisha, 751010
Phone: +91 9937000991
Email: CS@galaxymed.co.in
Website: http://www.galaxy.in/
Galaxy Medicare IPO Register
Cameo Corporate Services Ltd.
Phone: +91-44-28460390
Email: investor@cameoindia.com
Website: https://ipo.cameoindia.com/
Galaxy Medicare IPO Lead Manager
Affinity Global Capital Market Pvt.Ltd
